EXTON, Pa., May 12, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the appointment of West's Chief Financial Officer (CFO) Bernard J. Birkett to a newly combined position of Chief Financial and Operations Officer. In this expanded role, Mr. Birkett will lead our Global Operations and Global Supply Chain. The Company's Senior Vice President, Chief Global Operations and Supply Chain Officer, David Montecalvo has announced his resignation to pursue other interests with a departure of July 2022 to ensure a seamless transition.
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug and healthcare products, has introduced NovaGuard SA Pro Safety System, a single-use accessory for prefilled ISO standard 0.5ml staked needle syringes in India.
EXTON, Pa., Oct. 8, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2020 financial results before the market opens on Thursday, October 22, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 7564183.
Delivery device with West Pharmaceutical Services has completed the expansion of its plant in Mulhuddart, County Dublin.
Wes's Generic Oxycodone HCL Receives Approval In US
Up and Down the Ladder: The Latest Comings and Goings at Takeda, Regeneron and…